General Notices

• Pre-Application Webinars for NCI Cancer Screening Research Network (CSRN): ACCrual, Enrollment, and Screening Sites Hub (RFA-CA-23-020); Statistics and Data Management Center (RFA-CA-23-021); and Coordinating and Communication Center (RFA-CA-23-022)
  (NOT-CA-23-017)
  National Cancer Institute
  

• Notice of Informational Webinar for PAR-23-030 "Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP) (T32)"
  (NOT-GM-23-026)
  National Institute of General Medical Sciences
  

• Findings of Research Misconduct
  (NOT-OD-23-024)
  Office of the Director, NIH
  

• Request for Information (RFI): Priorities for Precision Cancer Prevention of Pancreatic and Liver Cancer Science at NCI
  (NOT-CA-23-014)
  National Cancer Institute
  

• Request for Information: Priorities for Cancer Prevention and Symptom Management Science at NCI
  (NOT-CA-23-016)
  National Cancer Institute
  

Notice of Changes to Funding Opportunities

• Notice of Correction to RFA-CA-22-050, NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional)".
  (NOT-CA-22-132)
  National Cancer Institute
  

• Clarification of Eligibility for Institutions with Multiple Campuses in PAR-21-026 "Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32 - Clinical Trial Not Allowed)"
  (NOT-GM-23-010)
  National Institute of General Medical Sciences
  

• Clarification of Eligibility for Institutions with Multiple Campuses in PAR-22-220 "Postbaccalaureate Research Education Program (PREP) (R25 - Independent Clinical Trial Not Allowed)"
  (NOT-GM-23-019)
  National Institute of General Medical Sciences
  

• Notice of Change to the Key Dates for PAR-20-049 "NINDS Postdoctoral Mentored Career Development Award (K01 - No Independent Clinical Trial Allowed)"
  (NOT-NS-23-044)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Change to the Key Dates for PAR-20-050 "NINDS Postdoctoral Mentored Career Development Award (K01 - Clinical Trial Required)"
  (NOT-NS-23-045)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Correction to Eligibility Criteria for RFA-NS-22-011 "BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)"
  (NOT-NS-23-047)
  National Institute of Neurological Disorders and Stroke
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics
  (NOT-AI-23-001)
  National Institute of Allergy and Infectious Diseases
  National Cancer Institute
  National Institute of Biomedical Imaging and Bioengineering
  

• Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Coccidioidomycosis (Valley fever) Vaccine
  (NOT-AI-23-007)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Special Interest (NOSI): Administrative Supplements to Prepare Data Assets for Infectious and Immune-mediated Diseases for Inclusion into the NIAID Data Ecosystem
  (NOT-AI-23-009)
  National Institute of Allergy and Infectious Diseases
  National Cancer Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of General Medical Sciences
  

• Notice of Special Interest (NOSI): Complement in Fundamental Immunology
  (NOT-AI-23-012)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Special Interest (NOSI): Advancing Research for Tickborne Diseases (TBDs)
  (NOT-AI-23-013)
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  

• Notice of Special Interest: Promoting Research Opportunities on HIV/AIDS in NIAMS
  (NOT-AR-23-004)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

Funding Opportunities

• Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required)
  (PAR-22-256)
  National Cancer Institute
  Application Receipt Date(s): November 17, 2025
  
  

• Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
  (PAR-23-025)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
  (PAR-23-026)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP)(T32)
  (PAR-23-030)
  National Institute of General Medical Sciences
  Application Receipt Date(s): January 27, 2025
  
  

• Testing Centers for Development of Somatic Cell Genome Editing in Model Organisms (U42) (Clinical Trials Not Allowed)
  (PAR-23-038)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): February 01, 2023
  
  

• Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed)
  (PAR-23-051)
  National Cancer Institute
  Application Receipt Date(s): October 23, 2025
  
  

• Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed)
  (PAR-23-052)
  National Cancer Institute
  Application Receipt Date(s): October 23, 2025
  
  

• Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)
  (PAR-23-053)
  National Institute on Aging
  Office of Research on Women's Health
  Application Receipt Date(s): December 02, 2025
  
  

• Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional)
  (PAR-23-054)
  National Institute on Aging
  Office of Research on Women's Health
  Application Receipt Date(s): December 02, 2025
  
  

• NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)
  (PAR-23-065)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): January 07, 2026
  
  

• International Centers of Excellence for Malaria Research (U19 Clinical Trial Not Allowed)
  (RFA-AI-22-067)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): May 04, 2023
  
  

• Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed
  (RFA-FD-23-012)
  Food and Drug Administration
  Application Receipt Date(s): March 22, 2023
  
  

• Assuring Radiation Protection (U18) Clinical Trial Not Allowed
  (RFA-FD-23-018)
  Food and Drug Administration
  Application Receipt Date(s): February 14, 2023
  
  

• Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed)
  (RFA-HD-24-006)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  Application Receipt Date(s): March 29, 2023
  
  

• Social Drivers of Mental Illnesses in Low- and Middle-Income Countries: Mechanisms and Pathways of Interventions for Youth (R01 Clinical Trial Optional)
  (RFA-MH-23-310)
  National Institute of Mental Health
  Application Receipt Date(s): February 17, 2023
  
  

• Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed)
  (RFA-RM-23-003)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): February 03, 2023